目的:为了进入磁共振成像(MRI)扫描仪,神经调节设备的发展一直是理解局限性之一,工程修改,以及在社区内达成共识,FDA可以安全地管理设备的标签。在神经调节的最初几十年里,它已被禁止与植入装置一起使用MRI。在这次审查中,我们采取了全面的方法来解决当前市场上的所有主要产品,以便为医生提供确定何时可以对每种类型的设备植入物进行MRI的能力。
方法:我们为目前上市的植入式神经调节装置(包括脊髓刺激器)准备了MRI指南的叙述性综述,鞘内给药系统,周围神经刺激器,深部脑刺激器,迷走神经刺激器,和骶神经刺激器.数据来源包括通过PubMed搜索确定的相关文献,MEDLINE/OVID,Scopus,以及手动搜索已知主要文章和评论文章的参考书目,以及制造商提供的信息。
结果:介绍了每种设备的指南和建议以及在MR环境中和周围使用的各自指南。
结论:这是美国疼痛与神经科学学会关于市场上各种设备和MRI兼容性的第一个综合指南。
OBJECTIVE: The evolution of neuromodulation devices in order to enter magnetic resonance imaging (MRI) scanners has been one of understanding limitations, engineering modifications, and the development of a
consensus within the community in which the FDA could safely administer labeling for the devices. In the initial decades of neuromodulation, it has been contraindicated for MRI use with implanted devices. In this review, we take a comprehensive approach to address all the major products currently on the market in order to provide physicians with the ability to determine when an MRI can be performed for each type of device implant.
METHODS: We have prepared a narrative review of MRI
guidelines for currently marketed implanted neuromodulation devices including spinal cord stimulators, intrathecal drug delivery systems, peripheral nerve stimulators, deep brain stimulators, vagal nerve stimulators, and sacral nerve stimulators. Data sources included relevant literature identified through searches of PubMed, MEDLINE/OVID, SCOPUS, and manual searches of the bibliographies of known primary and review articles, as well as manufacturer-provided information.
RESULTS: Guidelines and recommendations for each device and their respective
guidelines for use in and around MR environments are presented.
CONCLUSIONS: This is the first comprehensive
guideline with regards to various devices in the market and MRI compatibility from the American Society of Pain and Neuroscience.